02186 LUYE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.24X | Oper Margin | 23.1% |
|---|---|---|---|
| LT Debt/Equity | 19.3% | Net Margin | 7.8% |
| Total Debt/Equity | 72.9% | Return on Equity | 3.3% |
| Price/Book | 0.97X | Return on Assets | 1.6% |
| (HKD 3.880) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 501.85 | 587.04 | 678.11 | -164.37 | 838.58 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -14.5 | -13.4 | +512.5 | -119.6 | -46.3 |
| Earnings Per Share (HKD) | 0.133 | 0.158 | 0.195 | -0.048 | 0.263 |
| Earnings Per Share Growth (%) | -15.3 | -19.2 | +508.4 | -118.1 | -46.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 29.09 | 24.63 | 19.92 | N/A | 14.75 |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 4.002 | 3.672 | 3.214 | 2.932 | 2.883 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 3,181 | 3,075 | +3.4 | 2,904 |
| Operating Result | 469.662 | 529.632 | -11.3 | 228.756 |
| Associates | -12.022 | 0.345 | -3,584.6 | 0.232 |
| Profit Before Taxation | 457.64 | 529.977 | -13.6 | 228.988 |
| Taxation | 100.257 | 91.799 | +9.2 | 83.634 |
| Profit /( Loss) After Taxation | 357.383 | 438.178 | -18.4 | 145.354 |
| Minority Interests | 44.497 | 50.342 | -11.6 | -4.623 |
| Net Profit | 312.886 | 387.836 | -19.3 | 149.977 |
| Earnings Per Share () | 0.0911 | 0.1108 | -17.8 | 0.0438 |
| Announcement Date | 2025-08-28 | 2024-08-28 | NA | 2023-08-29 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
